Is there any relationship between autism and pineal gland volume? by Görgülü, Feride F. & Koç, Ayşe S.
e225
This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-Noncommercial-No Derivatives 4.0  
International (CC BY-NC-ND 4.0). License (https://creativecommons.org/licenses/by-nc-nd/4.0/).  






Is there any relationship between autism and pineal gland volume? 
Feride F. GörgülüA,B,C,D,E,F, Ayşe S. KoçA,B,D,E,F
Department of Radiology, University of Health Sciences, Adana Health Practice and Research Center, Adana, Turkey
Abstract
Purpose: Abnormalities in melatonin physiology and circadian rhythm are detected in patients with autism. Melatonin 
is produced predominantly in the pineal gland and the amount of melatonin released is proportional to the pineal 
gland volume. This study aimed to examine whether the pineal gland volume in children with autism is different 
from that in healthy children. 
Material and methods: Brain magnetic resonance images (MRI) of 120 paediatric patients with autism and 82 control 
paediatric subjects were examined; pineal parenchymal volume (PPV), pineal cyst rate (PCR), and total pineal gland 
volume (TPGV) were measured using a multimodality viewer (MMV), but only the TPGVs were measured using  
a tumour tracking (TT) method. Measurements were taken by 2 separate radiologists. 
Results: In patients with autism, the PPV and TPGV according to MMV, and the TPGV according to TT were sig-
nificantly lower, and the PCR was significantly higher. Moreover, the ratio of PPV to TPGV was significantly lower 
in the autism patient group. In both groups, the TPGVs were significantly lower in the autism patient group than 
the controls among all age groups.
Conclusions: Our study was the first to examine TPGVs in detail in paediatric patients with autism using 2 different 
methods. Low PPV-TPGV and high PCR have been observed in autism. This study also provides comparable refer-
ence values for pineal gland size in healthy children or autistic children aged 2-17 years. These results show promising 
potential for further research to understand the relationship between autism pathogenesis and the pineal gland. 
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Introduction
Autism spectrum disorder (ASD) is a complex neurodevel-
opmental disorder that is either congenital or occurs in the 
first 3 years of life, affecting 1% of the general population. 
The disease is characterized by disorders in communication 
and social interaction, accompanied by restrictive and repeti-
tive behaviour [1]. 
Abnormalities in melatonin physiology and circadian 
rhythm are detected in ASD patients. The physiological lev-
els of melatonin and/or melatonin derivatives are generally 
below average in ASD, and they are correlated with autistic 
behaviour. In children with autism, these abnormalities in 
melatonin concentrations have been reported to be due to 
variations in the melatonin production pathway and genetic 
pathways. The relationship between daytime behaviours and 
better night-time management of children with ASD who 
underwent exogenous treatment with melatonin supple-
ments was previously reported [2,3]. It has been observed 
that approximately 65% of patients with ASD have less than 
half the mean melatonin values. Furthermore, sleep distur-
bance is seen in 9-50% of normal children, but it is one of 
the most common symptoms in paediatric ASD patients, 
with a prevalence of 50-80% [4]. Melatonin is an endog-
enous neuro-hormone that is produced predominantly in 
the dark, at night in the pineal gland, and the amount of 
melatonin released is proportional to the volume of the pi-
neal gland [5]. 
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The pineal gland is a photo-neuro-endocrine gland pro-
truding from the posterior wall of the third ventricle in the 
centre of the brain. Its position enables it to provide direct 
secretion to the cerebrospinal fluid and to secret hormones 
into the blood [1]. The pineal parenchyma volume (PPV) 
(corrected pineal volume for individuals with pineal cysts), 
which represents the part that releases melatonin, can be 
considered to be proportional to the number and total vol-
ume of pinealocytes. Moreover, pineal cysts, which are very 
common but whose effects on pineal function are unknown, 
should also be considered in order to achieve the correct re-
sult when analysing the function of this gland [7,8]. 
This present study aimed to examine whether the total or 
parenchymal volume of the pineal gland in children with ASD 
is different from that in healthy children. Our second aim was 
to examine whether there is a difference between patients with 
ASD and control individuals in terms of the presence of a pi-
neal gland cyst. Our third target was to investigate whether 
there is a change in pineal gland volume (PGV) based on 
increasing age groups in ASD children and normal children. 
Finally, in light of the fact that knowing the normal pineal 
gland volume can help radiologists to identify abnormal cases, 
we also aimed to reveal normal pineal gland volumes in chil-
dren, which could be used to compare MRI findings.
Material and methods
Study population
A total of 120 children with definitively diagnosed ASD 
and 82 control paediatric subjects, with both groups aged 
2-17 years, from data obtained from Adana City Research 
and Training Hospital (Adana, Turkey), were included 
in this study. Patients diagnosed with ASD registered in 
the hospital database, who had undergone brain mag-
netic resonance imaging (MRI) and were between the age 
of 2 and 17 years, were included in the study. The PGVs of 
the paediatric patients from whom brain MRIs were taken 
for various reasons and evaluated as normal in similar age 
groups were selected as the control group. Patients and con-
trol subjects with pineal calcification, with history of a brain 
trauma, operation, and tumour history were excluded from 
the study. The patients’ parents gave their signed informed 
consent, which also provided them with a comprehensive 
description of the study. All procedures were approved by 
the Ethics Committee of Adana City Research and Training 
Hospital prior to initiation of this study.
Volumetric analysis
All the MRI studies were performed without contrast ad-
ministration on the same 3.0-Tesla scanner (Philips Medi-
cal Systems, Ingenia, Netherlands). We used the corpus 
callosum and the upper colliculus, the posterior part of the 
third ventricle, and the quadrigeminal cistern as the ana-
tomical landmarks to define the pineal gland. We marked 
and measured the volume of the pineal glands primarily in 
the sagittal planes and supported the results in axial and 
coronal planes. Volumetry of the pineal gland and pineal 
cysts was done using the volume analysis program, and 
3-dimensional (3-D) volumetric analysis was performed 
on a workstation using Philips Intellispace Portal software. 
There are 2 different volume measurement software in this 
program, one is a multimodality viewer (MMV) and the 
other is a tumour tracking (TT) method. The pineal gland 
parenchyma, cyst, and total gland volumes were mea-
sured in T1-weighted sequences using the MMV method 
(Figure 1). When describing the pineal cyst, we considered 
it to be a homogeneous area isointense to cerebrospinal 
fluid in T1-weighted images (Figure 2). Becuase it is tech-
nically difficult to distinguish between a pineal cyst and the 
parenchyma with TT, only total PGVs were measured in 
T1-weighted sequences using the TT method (Figure 3). 
The PPV was calculated by subtracting the volume of the 
Figure 1. Total pineal gland volume measurement of a 6-year-old male 
patient using the multimodality viewer method
Figure 2. In 3-dimensional T1-weighted sagittal section, pineal parenchyma 
was measured in manual bright selection by multimodality viewer method in 
magnetic resonance segmentation, while cyst volume was measured in dark 
selection. Blue arrow shows pineal cyst in a healthy 3-year-old child
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cyst from the total pineal volume, considering that pineal 
cysts do not contain pinealocytes. All volumetric data were 
given as means ± standard deviation (SD) in cubic mm 
from 2 different measurements that had a 1-week time gap 
between 2 measurements. The final value was determined 
by taking the average. 
The sequences of the study protocol images used in the 
volumetric measurements consisted of 3-D Brainview T1W, 
TSE (turbo spin echo) T2W – coronal, TSE T2W – axial, 
T1WIR (inversion recovery) – coronal, and Flair-SPIR (spec-
tral pre-saturation with inversion recovery)-axial. The file 
format was DICOM. The slice thicknesses were 1-3 mm. 
The study protocol of 3-D structural T1-weighted gradi-
ent echo sequences consisted of the following parameters: 
flip angle = 90°; field of view = 240 × 240 mm; repetition 
time = 600 ms; echo time = 29 ms; acquired voxel size = 0.99 
× 1.0 × 1.0 mm; 1.0 mm sagittal slice thickness without inter-
slice gap. Parameters of TSE (turbo spin echo) T2-weighted 
sequences were detailed as follows: acquisition voxel size = 
0.70 × 0.82 × 3.0 mm; 3.0 mm sagittal slice thickness with no 
inter-slice gap; repetition time = 4.2 ms; echo time = 103 ms; 
flip angle = 90°; field of view = 240 × 240 mm. 
Measurements were taken by 2 separate radiologists (FFG, 
ASK), who were unaware of the patients’ clinical diagnosis, 
using 1 of 2 methods; one method used a multimodality view-
er (MMV) by FFG and the other used tumour tracking (TT) 
by ASK. Both of the radiologists who took the measurements 
had 15 years of experience. 
Statistical analysis 
The Shapiro Wilk test was used to determine the normal-
ity of the continuous variables. Because the data showed 
normal distribution, Student’s t test was used to determine 
the average differences between the ASD patients and the 
control group. Pearson’s correlation coefficients were cal-
culated to determine the linear relationship between total 
pineal gland volume (TPGV)-MMV (mm3) and TPGV-TT 
(mm3) in the patient and control groups. To observe the 
compatibility between the TT and MMV techniques, the 
in-class correlation coefficient was calculated. Receiver ope-
rating characteristic (ROC) analysis was used to determine 
the cut-off point for TT and MMV and to compare the area 
under the 2 ROC curves. The c2 test was used to analyse the 
number of patients with cysts and the patients’ gender by 
group. Statistical significance level was taken as 0.05, and 
SPSS 21 and MedCalc 16 demo versions were used in the 
analyses.
Results
Age and gender were homogenously distributed between 
the 2 study groups (p = 0.688 for age, p = 0.650 for gender) 
(Table 1). Although the mean of the PPV was lower in the 
ASD patient group than in the control group, no signifi-
cant difference was found between the 2 groups in terms 
of mean pineal cyst volume (p < 0.001, p = 0.940, respec-
tively). The mean TPGV was lower in the patients with 
ASD than in the control group for both the MMV and TT 
techniques (p < 0.001 for both).  The average PPV-MMV/
Figure 3. Pineal gland volume of a 16-year-old male patient measured 
using the tumour tracking method
Table 1. Age and gender distribution of the autism spectrum disorder (ASD) 
patient and control groups
Parameter ASD Control p
Age (mean ± SD) 9.08 ± 4.44 8.82 ± 4.54 0.688a
Gender, n (%) 
Female 26 (21.7) 20 (24.4) 0.650b
Male 94 (78.3) 62 (75.6)
aStudent’s t-test, bc2 test
Table 2. Comparison of the distribution of the studied parameters by group
Parameter ASD (n = 120), mean ± SD Control (n = 82), mean ± SD p
PPV-MMV (mm3) 91.96 ± 45.09 139.22 ± 42.41 < 0.001a
PCV-MMV (mm3) 56.90 ± 24.32 57.38 ± 27.38 0.940a
TPGV-MMV (mm3) 120.26 ± 37.63 155.26 ± 35.93 < 0.001a
TPGV-TT (mm3) 134.34 ± 40.82 167.29 ± 37.29 < 0.001a
Number of patients with a pineal cyst (n) 60 (50.0%) 21 (25.6%) 0.001b
PPV-MMV/ TPGV-MMV rate 0.77 ± 0.26 0.90 ± 0.19 < 0.001a
aStudent’s t-test, bc2 test, ASD – autism spectrum disorder, PPV – pineal parenchyma volume, PCV – pineal cyst volume, TPGV – total pineal gland volume, MMV – multimodality viewer, 
TT – tumour tracking
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TPGV-MMV ratio was lower in patients with ASD than 
in the control group (p < 0.001). The rate of patients with 
a pineal cyst was higher in the patients with ASD than in 
the control group (p = 0.001) (Table 2). The mean TPGV 
volume was statistically significantly lower for patients with 
ASD in all age groups in comparison to the control group, 
based on both measurement techniques (Figures 4 and 5).
A positive, strong linear relationship was found be-
tween age and TPGV for both the ASD patient group and 
the control group, for both techniques. As the patients’ ages 
increased, the TPGV also increased (Table 3).
There was a very strong agreement between the TT and 
MMV techniques in terms of measuring the TPGV (intra-
class correlation [95% confidence interval] 0.961; range: 
0.948-0.970).
According to the TPGV-MMV technique, the cut-off point 
for distinguishing between patients with ASD and the healthy 
control subjects was ≤ 125 mm3. Based on this value, the rate 
of detecting patients with ASD was 53.33%, while the rate 
of detecting healthy children was 87.80%. According to the 
MMV technique, the overall discrimination performance for 
the TPGV was 74.2%. The cut-off point to differentiate patients 
with ASD from healthy patients was ≤ 150 mm3 when using 
the TPGV-TT technique. Based on this value, the rate of de-
tecting patients with ASD was 62.5%, while the rate of detect-
ing healthy children was 70.73%. The overall discrimination 
performance of the TPGV-TT technique was 71.3%.
However, this value was not statistically significant. There 
was no difference in the TPGV measurements between the 
2 techniques in terms distinguishing patients with ASD from 
healthy individuals (p = 0.056) (Table 4, Figure 6).
Discussion
According to our measurements obtained using MMV 
and TT, the TPGV was lower in patients with ASD than 
in the control group (p < 0.001). Moreover, the PPV and 
PPV-MMV/TPGV-MMV ratio were also found to be 
lower in the patients with ASD than in the control group 
(p < 0.001 for both).
In the 16th century, René Descartes defined the pineal 
gland as the “place of the soul” or the “organ of the psycho-
physiological control” [9]. The pineal gland is responsible 
for the synthesis of serotonin and N-N-dimethyltryptamine 
during the day and melatonin synthesis at night, with the 
circadian rhythm [10]. Although melatonin is known for its 
regulatory role in the circadian rhythm, it is also a powerful 
antioxidant, it has anti-inflammatory properties, and it helps 
regulate immune response and synaptic plasticity [11,12]. 
The pineal gland is situated on the sagittal line between 
the posterior commissure and the dorsal habenular commis-
sure. It is about 5-9 mm in length and 1-5 mm in width, and 
it has a solid, pinecone shaped and a red-grey colour [9,13]. 
In mammals, the size of the pineal gland depends on the cli-
Figure 4. Comparison of the total pineal gland volume measurements of the 
autism spectrum disorder patients and the controls in all age groups using 
the multimodality viewer (MMV) technique (p = 0.014 for 15-17-year-old 
age group; MMV, p < 0.001 for all the other age groups)
Figure 5. Comparison of the total pineal gland volume measurements of the 
autism spectrum disorder patients and the controls in all age groups using 
the tumour tracking (TT) technique (p = 0.011 for the 15-17-year-old age 
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Table 3. Analysis of the relationship between total pineal gland volume and 
age using both techniques
TPGV-MMV (mm3) TPGV-TT (mm3)
ASD–Age r 0.824 0.791
p < 0.001 < 0.001
Control–Age r 0.735 0.742
p < 0.001 < 0.001
r – Pearson’s correlation coefficient, ASD – autism spectrum disorder, TPGV – total pineal gland 
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mate, the geographic location, and the light stimulus activity 
[14]. The pineal gland consists of follicles and pinealocytes 
and glial tissue. The pinealocytes form the pineal parenchy-
ma and the astrocytes dominate the glial tissue [15]. As the 
PPV increases, the amount of melatonin secreted increases 
in direct proportion. The PPV only contains pinealocytes. 
The more parenchymal calcifications, gliosis, and cysts, the 
more dysfunctional the secretory activities of the gland [16].
In ASD, the physiological levels of melatonin and/or mel-
atonin derivatives are generally below average and are associ-
ated with autistic behaviour. In ASD, this might be due to the 
abnormalities in the genes associated with melatonin. Treat-
ment with melatonin supplementation significantly improves 
sleep time and sleep delay in ASD [17,18]. Maruani et al. [19] 
found that both early-morning melatonin level and pineal 
gland volume were lower in patients with ASD in compari-
son to the controls. Another study found that the PPV was 
linearly correlated with the plasma concentrations of mela-
tonin in humans [16]. That study showed similar differences 
between individuals with 24-hour melatonin per pineal tissue 
volume [16]. Examining the relationship between MRI volu-
metry and melatonin levels facilitates the characterization of 
the secretory capacity of the pineal gland. This is especially 
seen in diseases that include a disturbed circadian melatonin 
rhythm, such as schizophrenia, Parkinson’s disease, sleep dis-
orders, and aging [20-22]. We found the TPGV in patients 
with ASD to be low, in accordance with the literature, using 
both the MMV and TT methods. A brain imaging study in 
autistic patients reported abnormalities such as an increase in 
total brain volume and cerebellar abnormality [23]. 
Several rigorous radiological studies have been con-
ducted on PGV in normal and abnormal cases. Autistic chil-
dren can be calmed using mild anaesthesia when perform-
ing noninvasive imaging studies, such as brain MRIs [24]. 
A comprehensive study on pineal volume in healthy young 
adults reported that the mean pineal volume was 89.21 ± 
28.78 mm3 in male adults without cysts, and the true pineal 
volume in healthy adults was 94.2 ± 40.65 mm [3,25]. A sta-
tistically valuable study showed that the mean pineal volume 
was highest in the 31-40-year-old age group (158.34 ± 43.17 
mm3), the lowest mean volume was in the 41-50-year-old 
age group (109.90 ± 37.50 mm3), in the under 30-year-old 
age group the pineal volume was 131.47 ± 41.42 mm3, and in 
the over 50-year-old age group the pineal volume was 124.97 
± 39.79 mm3 [26]. 
Pineal calcifications are considered to be hormonally 
inactive [27]. This is common in autopsies and computed 
tomography, where it is seen in more than 66% of all cases 
[28,29]. The effect of pineal calcifications on melatonin secre-
tion is controversial. Kunz et al. [30] found no correlation 
between the degree of calcification and 24-hour sulphatox-
ymelatonin; however, they found a correlation between non-
calcified pineal tissue and 24-hour sulphatoxymelatonin. Due 
to this controversial situation, we did not include patients 
with calcification in our study.
The prevalence of pineal cysts was found to be 0.6% in 
children and 2.6% in adults [31]. Pineal cysts can be detected 
by chance using 3-T MRI. Furthermore, PGV tends to in-
crease with age [32]. In an MRI study in Iceland, the median 
volume of the pineal gland was found to be 207 mm3. This 
study also reported that the prevalence of cysts in this gland 
was 59% and the prevalence of calcifications was 20% [33]. 
Sumida et al. [7] reported that the size of the pineal gland 
increased from birth until 2 years of age and remained con-
stant from the ages of 2 to 20 years. In our study, the rate of 
patients with a pineal cyst was significantly higher in patients 
with ASD (50% vs. 25.6%), while no difference in the cyst 
volumes was observed between the patients with ASD and 
the control group (p = 0.001, p = 0.940, respectively). We 
also observed that the pineal volume increased with age in 
children with ASD.
This study has some limitations. First, the study popula-
tion was small because we could not include patients with pi-
neal calcification. Second, the study only included a volumet-
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Table 4. ROC curve analysis of MMV and TT to predict the paediatric autism spectrum disorder (ASD)
AUC (95% CI) Cut off, mm3 SE (95% CI) SP (95% CI) p
MMV 0.742 (0.676-0.801) ≤ 125 53.33 (44.0-62.5) 87.80 (78.7-94.0) < 0.001
TT 0.713 (0.645-0.774) ≤ 150 62.50 (53.2-71.2) 70.73 (59.6-80.3) < 0.001
Difference between areas 0.029 (-0.001 to 0.061) 0.056
p = ROC (receiver operating characteristic curves) analysis, AUC – area under curve, SE – sensitivity, SP – specificity, CI – confidence interval
Figure 6. ROC curve analysis of multimodality viewer and tumour tracking 
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between PGV and melatonin. However, we also evaluated the 
parenchyma volume associated with direct melatonin release. 
Thirdly, the effect of antipsychotic drugs used by patients was 
not taken into consideration. Finally, we included patients 
with pineal cysts, but it was useful to compare the presence 
and volume of cysts in patients with ASD and the subjects in 
the control group.
Conclusions
Our study was the first work in the literature to show that 
autistic children had significantly lower total and paren-
chymal pineal gland volumes in comparison to normal 
children, using 2 different measurement methods (MMV 
and TT). We found the rate of pineal cysts was signifi-
cantly higher in the children with ASD than in the healthy 
controls. We showed that the pineal volume in healthy 
children or children with ASD is dependent on age. This 
study also provides the normal distribution rate for the 
volumes of normal pineal glands in healthy children and 
autistic children aged between 2 and 17 years. We believe 
that further clarification and investigation of the abnormal 
findings we detected in ASD is warranted; in the future, 
more comprehensive and detailed studies will provide 
beneficial results for the pathogenesis of ASD patients.
Conflict of interest
The authors report no conflict of interest.
References
1. Yenkoyan K, Grigoryan A, Fereshetyan K, et al. Advances in under-
standing the pathophysiology of autism spectrum disorders. Behav 
Brain Res 2017; 331: 92-101. 
2. Cohen S, Conduit R, Lockley SW, et al. The relationship between 
sleep and behavior in autism spectrum disorder (ASD): a review. 
J Neurodev Disord 2014; 6: 44. 
3. Rossignol DA, Frye RE. Melatonin in autism spectrum disorders: 
a systematic review and meta-analysis. Dev Med Child Neurol 2011; 
53: 783-792.
4. Geoffray MM, Nicolas A, Speranza M, et al. Are circadian rhythms 
new pathways to understand Autism Spectrum Disorder? J Physiol 
Paris 2016; 110: 434-438. 
5. Emet M, Ozcan H, Ozel L, et al. A review of melatonin, its receptors 
and drugs. Eurasian J Med 2016; 48: 135-141. 
6. Shen MD, Kim SH, McKinstry RC, et al. Increased extra-axial cere-
brospinal fluid in high-risk infants who later develop autism. Biol 
Psychiatry 2017; 82: 186-193. 
7. Sumida M, Barkovich AJ, Newton TH. Development of the pineal gland: 
measurement with MR. AJNR Am J Neuroradiol 1996; 17: 233-236.
8. Pu Y, Mahankali S, Hou J, et al. High prevalence of pineal cysts in 
healthy adults demonstrated by high-resolution, noncontrast brain 
MR imaging. AJNR Am J Neuroradiol 2007; 28: 1706-1709.
9. Nichols DE. N,N-dimethyltryptamine and the pineal gland: separat-
ing fact from myth. J Psychopharmacol 2018; 32: 30-36.
10. Pfeffer M, Korf HW, Wicht H. Synchronizing effects of melatonin on 
diurnal and circadian rhythms. Gen Comp Endocrinol 2018; 258: 
215-221.
11. Malow BA, Findling RL, Schroder CM, et al. Sleep, growth, and 
puberty after two years of prolonged-release melatonin in children 
with autism spectrum disorder. J Am Acad Child Adolesc Psychiatry 
2021; 60: 252-261.
12. El-Ansary A, Hassan WM, Daghestani M, et al. Preliminary evalu-
ation of a novel nine-biomarker profile for the prediction of autism 
spectrum disorder. PLoS One 2020; 15: e0227626.
13. Patel S, Rahmani B, Gandhi J, et al. Revisiting the pineal gland: 
a review of calcification, masses, precocious puberty, and melatonin 
functions. Int J Neurosci 2020; 130: 464-475. 
14. Tan DX, Xu B, Zhou X, et al. Pineal calcification, melatonin produc-
tion, aging, associated health consequences and rejuvenation of the 
pineal gland. Molecules 2018; 23: E301. 
15. Koshy S, Vettivel SK. Varying appearances of calcification in human 
pineal gland: a light microscopic study. J Anat Soc India 2001; 50: 
17-18. 
16. Nölte I, Lütkhoff AT, Stuck BA, et al. Pineal volume and circadian 
melatonin profile in healthy volunteers: an interdisciplinary ap-
proach. J Magn Reson Imaging 2009; 30: 499-505.
17. Jenabi E, Ataei S, Bashirian S. Evaluation of drug interventions 
for the treatment of sleep disorders in children with autism spec-
trum disorders: a systematic review. Korean J Pediatr 2019; 62: 
405-409.
18. Cuomo BM, Vaz S, Lee EAL, et al. Effectiveness of sleep-based inter-
ventions for children with autism spectrum disorder: a meta-synthe-
sis. Pharmacotherapy 2017; 37: 555-578. 
19. Maruani A, Dumas G, Beggiato A, et al. Morning plasma melatonin 
differences in autism: beyond the impact of pineal gland volume. 
Front Psychiatry 2019; 10: 11. 
20. Pandi-Perumal SR, Srinivasan V, Spence DW, et al. Role of the mela-
tonin system in the control of sleep: therapeutic implications. CNS 
Drugs 2007; 21: 995-1018.
21. Mayo JC, Sainz RM, Tan DX, et al. Melatonin and Parkinson’s dis-
ease. Endocrine 2005; 27: 169-178.
22. Pacchierotti C, Iapichino S, Bossini L, et al. Melatonin in psychiat-
ric disorders: a review on the melatonin involvement in psychiatry. 
Front Neuroendocrinol 2001; 22: 18-32.
23. Boddaert N, Zilbovicius M. Functional neuroimaging and childhood 
autism. Pediatr Radiol 2002; 32: 1-7.
24. Ross AK, Hazlett HC, Garrett NT, et al. Moderate sedation for MRI 
in young children with autism. Pediatr Radiol 2005; 35: 867-71.
25. Sun B, Wang D, Tang Y, et al. The pineal volume: a three-dimensional 
volumetric study in healthy young adults using 3.0 T MR data. Int 
J Dev Neurosci 2009; 27: 655-660.
26. Golan J, Torres K, Staśkiewicz GJ, et al. Morphometric parameters of 
the human pineal gland in relation to age, body weight and height. 
Folia Morphol (Warsz) 2002; 61: 111-113.
 Any relationship between autism and pineal gland volume?
e231© Pol J Radiol 2021; 86: e225-e231
27. Schmid HA, Requintina PJ, Oxenkrug GF, et al. Calcium, calcifica-
tion, and melatonin biosynthesis in the human pineal gland: a post-
mortem study into age-related factors. J Pineal Res 1994; 16: 178-183.
28. Hasegawa A, Ohtsubo K, Mori W. Pineal gland in old age; quantita-
tive and qualitative morphological study of 168 human autopsy cases. 
Brain Res 1987; 409: 343-349.
29. Daghighi MH, Rezaei V, Zarrintan S, et al. Intracranial physiologi-
cal calcifications in adults on computed tomography in Tabriz, Iran. 
Folia Morphol 2007; 66: 115-119.
30. Kunz D, Schmitz S, Mahlberg R, et al. A new concept for melatonin 
deficit: on pineal calcification and melatonin excretion. Neuropsy-
chopharmacology 1999; 21: 765-772.
31. Sener RN. The pineal gland: a comparative MR imaging study in 
children and adults with respect to normal anatomical variations and 
pineal cysts. Pediatr Radiol 1995; 25: 245-248.
32. Whitehead MT, Oh CC, Choudhri AF. Incidental pineal cysts in chil-
dren who undergo 3-T MRI. Pediatr Radiol 2013; 43: 1577-1583. 
33. Sigurdardottir LG, Markt SC, Sigurdsson S, et al. Pineal gland vol-
ume assessed by MRI and its correlation with 6-Sulfatoxymelatonin 
levels among older men. J Biol Rhytms 2016; 31: 461-469.
